Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Airbus announced that, on Jan. 21, 2025, the A320 ATRA (Advanced Technology Research Aircraft) flew for the first time from the German Aerospace Center (DLR) in Braunschweig, Germany, after the ...

Shares of Atara Biotherapeutics (NASDAQ:ATRA) continued to trade lower in the premarket on Tuesday after the U.S. Food and Drug Administration (FDA) slapped the cell therapy developer with a ...

Price Action: ATRA stock is down 4.09% at $6.302 at last check Tuesday.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The modified A320 ATRA also carried out high speed taxi tests. Credit: Peter R Foster IDMA/Shutterstock. Airbus has revealed the completion of ‘first flight’ for German Aerospace Center’s (DLR) ...

FDA halts Atara's EBVALLO and ATA3219 trials over manufacturing issues. Atara eyes $60 million milestone from Pierre Fabre upon EBVALLO approval.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.